Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies
PHASE3CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
August 1, 2016
Primary Completion Date
November 13, 2019
Study Completion Date
November 13, 2019
Conditions
Rabies
Interventions
DRUG
KamRAB - HRIG
wound infiltration or IM injection
Trial Locations (1)
12345
ACH, Little Rock
All Listed Sponsors
collaborator
Kedrion S.p.A.
INDUSTRY
lead
Kamada, Ltd.
INDUSTRY
NCT02912845 - Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies | Biotech Hunter | Biotech Hunter